IDEXX Laboratories (IDXX) free cash flow

Free cash flow · fiscal 2025
$1.04B

IDEXX Laboratories (IDXX) generated free cash flow of $1.04B in fiscal 2025 (the year ended December 31, 2025). That is 30.8% higher than the $798.08M of fiscal 2024. Figures as of 18 Nov 2026, 12:43 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$1.04B
Change on fiscal 2024
+30.8%
Growth, 5 years
+14.0% a year
Growth, 10 years
+22.3% a year
Highest on record
$1.04Bfiscal 2025
Lowest on record
$53.34Mfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

IDEXX Laboratories free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 14.0% a year; over ten years the rate was 22.3% a year. Across the 18 fiscal years on record (2008–2025), the highest was $1.04B in fiscal 2025 and the lowest $53.34M in fiscal 2008.

History · 18 fiscal years

Free cash flow by fiscal year

IDEXX Laboratories free cash flow, year by year

IDEXX Laboratories (IDXX) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$1.04B 30.8% up
2024$798.08M 3.3% up
2023$772.88M 101.2% up
2022$384.15M 39.6% down
2021$636.00M 17.5% up
2020$541.11M 77.9% up
2019$304.19M 7.0% up
2018$284.33M 4.9% down
2017$298.89M 9.0% up
2016$274.16M 97.4% up
2015$138.88M 20.8% down
2014$175.32M 4.1% up
2013$168.38M 2.2% up
2012$164.79M 2.0% down
2011$168.24M 20.2% up
2010$139.93M 12.6% up
2009$124.29M 133.0% up
2008$53.34M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of IDEXX Laboratories and comparable companies
CompanyFree cash flowFiscal year
argenx ARGX$573.51M2025
Edwards Lifesciences EW$1.34B2025
Becton, Dickinson BDX$2.67B2025
IDEXX Laboratories IDXX$1.04B2025
Medline MDLN$1.30B2025
Humana HUM$375.00M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on IDXX

IDEXX Laboratories, figure by figure

IDEXX Laboratories (IDXX) overview: price, valuation and scorecardAll health care companies by market value

IDEXX Laboratories free cash flow: questions and answers

What is IDEXX Laboratories's free cash flow?

IDEXX Laboratories (IDXX) generated free cash flow of $1.04B in fiscal 2025 (the year ended December 31, 2025). That is 30.8% higher than the $798.08M of fiscal 2024.

What is the growth rate of IDEXX Laboratories's free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 14.0% a year; over ten years the rate was 22.3% a year.

What are the highest and lowest free cash flow figures on record for IDEXX Laboratories?

Across the 18 fiscal years on record (2008–2025), the highest was $1.04B in fiscal 2025 and the lowest $53.34M in fiscal 2008.

How is IDEXX Laboratories's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For IDEXX Laboratories it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “IDEXX Laboratories (IDXX) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/IDXX/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.